Status:
COMPLETED
The Use of an Innovative Device for Therapeutic Adherence in Pediatric Asthma
Lead Sponsor:
Istituto per la Ricerca e l'Innovazione Biomedica
Conditions:
Asthma
Eligibility:
All Genders
6-17 years
Phase:
PHASE4
Brief Summary
The management of chronic diseases requires a constant monitoring of treatment adherence, in order to obtain an optimal disease control. However, this is often difficult to achieve, especially in pedi...
Eligibility Criteria
Inclusion
- \- uncontrolled mild or moderate persistent asthma;
Exclusion
- acute upper respiratory infections;
- immunological or metabolic systemic disease;
- major malformations of the upper airways;
- active smokers.
Key Trial Info
Start Date :
January 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 23 2020
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03788395
Start Date
January 10 2019
End Date
January 23 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council
Palermo, Sicily, Italy, 90146